70 related articles for article (PubMed ID: 519917)
1. Nolvadex (tamoxifen) following combination chemotherapy in progressive advanced breast cancer.
Edelstyn GA; Jeffrey L; MacRae KD
Clin Oncol; 1979 Dec; 5(4):325-30. PubMed ID: 519917
[No Abstract] [Full Text] [Related]
2. The management of locally advanced carcinoma of the breast by Nolvadex (tamoxifen): a pilot study.
Campbell FC; Morgan DA; Bishop HM; Benton FM; Blamey RW; Elston CW; Nicholson RI; Griffiths K
Clin Oncol; 1984 Jun; 10(2):111-5. PubMed ID: 6734002
[TBL] [Abstract][Full Text] [Related]
3. Rechallenging breast cancer with tamoxifen therapy.
Stoll BA
Clin Oncol; 1983 Dec; 9(4):347-51. PubMed ID: 6198122
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen in the management of advanced breast carcinoma in Nigerian women.
Senbanjo RO; Ihekwaba FN; Ajayi OO
West Afr J Med; 1990; 9(1):44-9. PubMed ID: 1702986
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of tamoxifen versus combined tamoxifen and diethylstilboestrol in advanced breast cancer in postmenopausal women.
Mouridsen HT; Salimtschik M; Dombernowsky P; Gelshoj K; Palshof T; Rorth M; Daehnfeldt JL; Rose C
Eur J Cancer (1965); 1980; Suppl 1():107-10. PubMed ID: 7032918
[No Abstract] [Full Text] [Related]
6. [Effectiveness of Nolvadex in the treatment of advanced breast cancer in the menopause].
Serkies K; Karnicka-Młodkowska A
Pol Tyg Lek; 1981 Jul; 36(29):1111-3. PubMed ID: 7312686
[No Abstract] [Full Text] [Related]
7. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
Buzdar AU; Powell KC; Blumenschein GR
Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined tamoxifen and medroxyprogesterone treatment on coagulation-fibrinolytic systems in patients with advanced breast cancer.
Fukutomi T; Adachi I; Watanabe T; Nanasawa T; Yamamoto H
Acta Oncol; 1993; 32(5):573-4. PubMed ID: 8217244
[No Abstract] [Full Text] [Related]
9. Adjuvant treatment for breast cancer in the elderly.
Marchei P; Bianco V; Pignatelli E; Chiodini S; Santini D; Carico E; Marchei M; Vecchione A
Anticancer Res; 1996; 16(2):911-3. PubMed ID: 8687150
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancer.
Krook JE; Ingle JN; Green SJ; Bowman WD; Everson LK; Windschitl HE; Marschke RF; Laurie JA; Cullinan SA; Pfeifle DM
Cancer Treat Rep; 1985 Apr; 69(4):355-61. PubMed ID: 3888386
[TBL] [Abstract][Full Text] [Related]
11. Extended tamoxifen therapy for advanced breast cancer. Clinical experience at Siriraj Hospital.
Tepmongkol P; Suphaphongs N; Chantarakul N; Thansakul A
J Med Assoc Thai; 1986 Dec; 69(12):635-40. PubMed ID: 3572276
[No Abstract] [Full Text] [Related]
12. CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trial.
Mouridsen HT; Palshof T; Engelsman E; Sylvester R
Eur J Cancer (1965); 1980; Suppl 1():119-23. PubMed ID: 7032921
[No Abstract] [Full Text] [Related]
13. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
14. [Management of advanced breast cancer in post-menopausal women. A comparative trial of hormonal therapy, chemotherapy, and a combination of both].
Clavel B; Cappelaere JP; Guerin J; Klein T; Pommatau E; Berlie J
Sem Hop; 1982 Sep; 58(34):1919-23. PubMed ID: 6293073
[TBL] [Abstract][Full Text] [Related]
15. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG
Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679
[TBL] [Abstract][Full Text] [Related]
16. The effect of adjuvant tamoxifen: the latest results from the Cancer Research Campaign Adjuvant Breast Trial. Cancer Research Campaign Breast Cancer Trials Group.
Eur J Cancer; 1992; 28A(4-5):904-7. PubMed ID: 1524921
[TBL] [Abstract][Full Text] [Related]
17. Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer.
Harvey HA; Lipton A; White DS; Santen RJ; Boucher AE; Shafik AS; Dixon RJ
Cancer Res; 1982 Aug; 42(8 Suppl):3451s-3453s. PubMed ID: 6177405
[TBL] [Abstract][Full Text] [Related]
18. [Antiestrogens in the treatment of advanced breast cancer].
Płuzańska A; Smiałowska A; Stempczyńska J; Wator A
Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):191-4. PubMed ID: 2813178
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy and tamoxifen for breast cancer.
N Engl J Med; 1981 Oct; 305(17):1014-5. PubMed ID: 7278914
[No Abstract] [Full Text] [Related]
20. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
